---
title: "Bridgebio Pharma Inc — Ownership Dossier"
canonical: https://whiteintel.dev/entity/be7e1fe4-e04f-4164-9aee-fb373c3180c4
json: https://whiteintel.dev/api/public/dossier/be7e1fe4-e04f-4164-9aee-fb373c3180c4
identifier: gb-coh:7424449
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Bridgebio Pharma Inc

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:7424449`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/be7e1fe4-e04f-4164-9aee-fb373c3180c4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/be7e1fe4-e04f-4164-9aee-fb373c3180c4  

## Ownership & control

### Holdings / subsidiaries

- **BRIDGEBIO UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/acfb27e0-6d73-5f91-a816-b43cd7324de5

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Bridgebio Pharma Inc**. Human view: https://whiteintel.dev/entity/be7e1fe4-e04f-4164-9aee-fb373c3180c4 · Structured JSON: https://whiteintel.dev/api/public/dossier/be7e1fe4-e04f-4164-9aee-fb373c3180c4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._